MedDataX Logo

Uterine Cavity Volume Measuring With Sonohysterography: A New Objective Method

NCT ID: NCT03777566

Last Updated: 2019-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

185 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-10

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measuring of uterine cavity volume using sonohysterography will be done in two groups of patients, Group A included 35 patients for home hysterectomy were indicated and group B includes 150 infertile patients in the childbearing age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Uterine cavity volume will be measured in group A before and after hysterectomy, and in the group, B will be measured using sonohysterography only using a mathematical method of the sum of a volume of a cone and part of a sphere.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cavity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

35 patients with an indication for hysterectomy without gross uterine pathology

sonohysterography

Intervention Type DIAGNOSTIC_TEST

sonohysterography with measuring the uterine cavity volume

group B

150 infertile patients in the childbearing age without gross uterine pathology

sonohysterography

Intervention Type DIAGNOSTIC_TEST

sonohysterography with measuring the uterine cavity volume

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sonohysterography

sonohysterography with measuring the uterine cavity volume

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients without any gross pathology within the uterus.
2. Patients admitted for hysterectomy.
3. Patients agreed with written consent to participate in the study.

Exclusion Criteria

1. Virgins.
2. Pregnancy.
3. Systemic blood disease.
4. Any clinical evidence of cervical, uterine or tubal infection.
5. Refusal to undergo saline infusion sonography.
6. Any gross uterine pathology diagnosed clinically or with sonography.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed I Amer

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed I Amer, MD

Role: PRINCIPAL_INVESTIGATOR

Ain Shams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AIn Shams University Maternity Hospital

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohamed I Amer, MD

Role: CONTACT

Phone: 00201001519370

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohamed Amer, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mohamed amer

Identifier Type: -

Identifier Source: org_study_id